240-year-old drug could save UK NHS £100 million a year treating common heart rhythm disorder
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...
Atrial Fibrillation Drugs Market Size to Worth USD 62.64 Billion by 2033 | Straits Research
The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...
The Conversation on MSN9d
Targeting One Enzyme May Prevent Obesity-Induced Heart Disease, Study Suggests
Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...
PharmiWeb2d
Atrial Fibrillation Device Market: Growth, Trends, and Future Outlook
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...
Flossing may reduce risk for stroke and irregular heart rhythm
Flossing regularly may lower the risk of some strokes as well as a type of irregular heart rhythm that can increase stroke risk, new research suggests.
Nature7d
Atrial Fibrillation Research
Atrial fibrillation (AF) is a common heart rhythm disorder characterized by rapid and irregular beating of the atria. It can lead to serious complications, including stroke and heart failure.